
Seeing a Better Way for Eye Drug R&D, Character Bio Lands $93M for Two Trials in Dry AMD
A clinical trial is typically the first look at how an experimental drug works in humans. Character Biosciences is entering the clinic with a trove of company-generated human data already in hand. These data inform Character’s approach to targets for the …